Customized PCR-array analysis informed by gene-chip microarray and biological hypothesis reveals pathways involved in lung inflammatory response to titanium dioxide in pregnancy.
Validation of gene-chip microarray results is one of the challenges in genomic studies. The successful use of a custom-designed 96-well polymerase chain reaction (PCR) array to study the unexpected inflammatory effect of environmental titanium dioxide (TiO2) particles on the lungs of pregnant mice, with similar results not seen in control mice, is reported. In our approach, selection of candidate genes for the custom PCR array was informed by prior gene-chip microarray profiling. Results demonstrated multiple upregulation of genes in the lungs of pregnant but not control mice produced by TiO2 exposure. Customized PCR array is a flexible tool that offers the ability to combine the "blind" genome-wide scan with a hypothesis-driven approach, by including both the "candidate" genes for validation positively identified by the microarray and biologically relevant "suspects" that failed to be found in the genomic data. Compared to conventional gene-by-gene qPCR or manufacturer-preset pathway kits, this technique provides a cost-effective and time-saving method of analysis and allows for a strong, easily detectable signal. Genes with confirmed differential expression were further used for pathway analysis and indicated involvement in several biologically relevant pathways including allergy mediator signaling in dendritic cells. Finally, an analytical network was created that will inform further mechanistic studies. The dual purpose of the work was to demonstrate that the novel custom PCR array is a convenient approach to validate the microarray results, and to obtain biologically significant data on TiO2-induced inflammation by following the PCR array with pathway analysis, which provided feasible hypotheses to support future experimental studies.
Lamoureux
Denise P
DP
Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts, USA.
Kobzik
Lester
L
Fedulov
Alexey V
AV
D000281:Administration, Intranasal; D000818:Animals; D005260:Female; D020869:Gene Expression Profiling; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects*; D019570:Inhalation Exposure; D008168:Lung; D055370:Lung Injury / Q000139:chemically induced* / Q000235:genetics; D018811:Maternal Exposure; D051379:Mice; D008807:Mice, Inbred BALB C; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods*; D010316:Particle Size; D011247:Pregnancy; D012333:RNA, Messenger / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods*; D014025:Titanium / Q000633:toxicity*; D015854:Up-Regulation / Q000187:drug effects*
D012333:RNA, Messenger; C009495:titanium dioxide; D014025:Titanium
J Mol Diagn. 2001 Feb;3(1):26-31
11227069
J Toxicol Environ Health A. 2008;71(5):315-24
18214805
Occup Environ Med. 2004 May;61(5):442-7
15090666
Respir Res. 2005 Apr 13;6:34
15829015
Am J Respir Cell Mol Biol. 2008 Jan;38(1):57-67
17656681
Adv Exp Med Biol. 2007;593:66-73
17265717
Toxicol Sci. 2005 Dec;88(2):514-24
16177240
Methods. 2001 Dec;25(4):443-51
11846613
Adv Immunol. 2009;101:123-61
19231594
Immunology. 2006 Apr;117(4):507-16
16556265
Lung. 1999;177(1):9-19
9835630
Genes Nutr. 2008 Dec;3(3-4):153-7
19034552
Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):496-503
16700885
Environ Res. 2009 Apr;109(3):239-44
19200952
Am J Respir Cell Mol Biol. 2005 Sep;33(3):290-6
15961726
Toxicol Appl Pharmacol. 2007 Aug 15;223(1):1-9
17561223